Evan switched to a different FVIII – how do these compare with novel therapies?
Evan found he could do more after he switched to a factor VIII product that offered the potential for fewer infusions.
Why choose a factor VIII product?
- Factor VIII products have remained the standard of care in hemophilia A for over 30 years1,2
- Factor VIII products are a continually evolving class of treatments that offer a spectrum of benefits to people with hemophilia A today.1,2Ask your doctor about how factor VIII products could benefit you
New hemophilia therapies that work differently to factor VIII product are now starting to emerge, but at the moment we don’t know exactly how effective or tolerable these novel treatments are in the long term.1,2
Experts predict the next big breakthrough in the treatment of hemophilia will come from gene therapy.2
- Aledort et al. Blood Transfus 2019; 17(6): 479–486. Return to content
- Mannucci et al. Haematologica 2020; 105(3): 545-553. Return to content